PYX-201 Phase 1 trial clinical readout on track for fall of 2024Executive Leadership Team expanded with the appointment of ...
Anheuser-Busch InBev reported higher-than-expected revenue in the first quarter despite lower sales in the U.S. and China ...
TEL AVIV, Israel and MIAMI, May 14, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the treatment of carotid artery disease (CAD) ...
The Company reported Basic and Diluted Earnings Per Share of fils 17 for Q1 2024 versus fils 34 for the same period in 2023 ...
Baron Funds, an investment management company, released its “Baron Asset Fund” first quarter 2024 investor letter. A copy of ...
The bounce has overlapped with a stronger-than-expected first-quarter reporting season for U.S. companies. With well over 80% ...
DOYLESTOWN, Pa., May 14, 2024 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company focused on precision oncology through ...
Gross margin for the three months ended March 31, 2024 was 14%, representing an increase from 13% for the same period in 2023. Excluding deferred revenue, gross margin for the first quarter of 2024 ...
NVIDIA stock is displacing gold as a hedge against inflation as its shares have printed an impressive rally in the past ...
Asian shares hovered around 15-month highs on Tuesday and the dollar was firm ahead of highly anticipated U.S. inflation data ...